Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition
115 Interactive Exhibits, Research Capsules and Live Laboratory Experiences Explore the Science of Health and Wellbeing in the 21st Century
TUCSON, Ariz. – May 23, 2013 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the Glasgow Science Centre in Scotland, which boasts more than 380,000 visitors annually, is featuring the SynCardia temporary Total Artificial Heart powered by the Freedom® portable driver as part of its $3 million Bodyworks Exhibition, one of the most advanced exhibitions of its kind.
"BodyWorks combines the latest technology with an excellent approach to story-telling to define and explain that most complex of entities, the human body," said Dr. Stephen Breslin, chief executive of Glasgow Science Centre.
The "Heart Pod" featuring the SynCardia Total Artificial Heart powered by the Freedom portable driver is one of 115 interactive exhibits, research capsules and live laboratory experiences that explore the science of health and wellbeing in the 21st Century. In order to demonstrate the innovative engineering behind this life-saving technology, the museum fabricated a full-size, semi-transparent human torso, which includes the skeletal system and internal organs.
Other exhibits for adults and children include:
- A virtual autopsy table, the only one of its kind in the United Kingdom
- A giant "hamster wheel" which measures stamina
- A "DNA disco" that explains genetic science in an entertaining way
- Plastinated human tissue samples that explain the make-up of the body
The Centre, which is the biggest of its kind outside London, is an award-winning, independent educational charity. Last year, more than 477,000 people experienced the museum's exhibits, with more than 388,892 admissions to the Centre itself, and another 88,141 people reached via programming brought directly to local schools and communities.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, firstname.lastname@example.org, (520) 547-7463